Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRI) Interest & Investment Income (2023 - 2025)

Historic Interest & Investment Income for Biofrontera (BFRI) over the last 3 years, with Q3 2025 value amounting to -$111000.0.

  • Biofrontera's Interest & Investment Income fell 148750.0% to -$111000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$372000.0, marking a year-over-year increase of 8314.45%. This contributed to the annual value of -$2.0 million for FY2024, which is 33482.91% down from last year.
  • Latest data reveals that Biofrontera reported Interest & Investment Income of -$111000.0 as of Q3 2025, which was down 148750.0% from -$115000.0 recorded in Q2 2025.
  • In the past 5 years, Biofrontera's Interest & Investment Income registered a high of $56000.0 during Q1 2023, and its lowest value of -$1.4 million during Q1 2024.
  • Its 3-year average for Interest & Investment Income is -$238454.5, with a median of -$111000.0 in 2025.
  • Examining YoY changes over the last 5 years, Biofrontera's Interest & Investment Income showed a top increase of 10563.38% in 2024 and a maximum decrease of 261250.0% in 2024.
  • Biofrontera's Interest & Investment Income (Quarter) stood at -$212000.0 in 2023, then skyrocketed by 81.13% to -$40000.0 in 2024, then crashed by 177.5% to -$111000.0 in 2025.
  • Its Interest & Investment Income stands at -$111000.0 for Q3 2025, versus -$115000.0 for Q2 2025 and -$106000.0 for Q1 2025.